Divi's Labs Q3 net up 11.77% at Rs 246.56 cr

Pharmaceuticals firm Divi's Laboratories today reported a 11.77 per cent rise in standalone net profit at Rs 246.56 crore for the quarter ended December 31.

The company had posted a standalone net profit of Rs 220.58 crore in the same period last fiscal, it said in a BSE filing.

Net sales during the period under review rose by 8 per cent to Rs 851.77 crore as against Rs 788.08 crore in the year-ago period.

The company, which is primarily engaged in manufacturing of active pharmaceutical ingredients and intermediates, said during the quarter it had a forex gain of Rs 3 crore as against Rs 11 crore in the corresponding period last fiscal.
 

Divi's Laboratories shares today closed at Rs 1.43 per cent up at Rs 1,104.15 apiece on the BSE.